Q16539 MK14_HUMAN
Gene name: MAPK14
Protein name: Mitogen-activated protein kinase 14
List of molecules and drugs that target protein Q16539
| # | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
|---|---|---|---|---|---|---|---|
| 1 | Q16539_DB01254 | DB01254 | Dasatinib | n/a | IC50(nM) = 100.0 Kd(nM) = 27.0 EC50(nM) = 470.0 | ZBNZXTGUTAYRHI-UHFFFAOYSA-N | CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1 |
| 2 | Q16539_DB01761 | DB01761 | 4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine | n/a | IC50(nM) = 0.11 | QICPQLFMWYQJGX-SFHVURJKSA-N | C[C@H](NC1=NC(=CC=N1)C1=C(N=C(C2CCNCC2)N1C)C1=CC=CC(=C1)C(F)(F)F)C1=CC=CC=C1 |
| 3 | Q16539_DB01807 | DB01807 | N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea | n/a | XIWRCSVXKPGGAJ-UHFFFAOYSA-N | CC(C)(C)C1=NN(C(NC(=O)NC2=CC=C(Cl)C=C2)=C1)C1=CC=CC=C1 | |
| 4 | Q16539_DB01948 | DB01948 | 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One | n/a | IC50(nM) = 0.74 | VXIYTVJEIXMAQF-UHFFFAOYSA-N | FC1=CC=C(C(F)=C1)C1=CC(=CC2=C1CCC(=O)N2C1=C(Cl)C=CC=C1Cl)C1CCNCC1 |
| 5 | Q16539_DB01953 | DB01953 | Inhibitor of P38 Kinase | n/a | IC50(nM) = 35000.0 | UUEYCHLWAOBOHG-UHFFFAOYSA-N | C(CC1=CC=NC=C1)C1=CNC2=CC=CC=C12 |
| 6 | Q16539_DB01988 | DB01988 | 6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine | n/a | WFSFNKVFXLIZIY-MHZLTWQESA-N | C([C@H]1CN(CCN1)C1=NN=C(C2=CC3=CC=CC=C3C=C2)C(=C1)C1=CC=NC=C1)C1=CC=CC=C1 | |
| 7 | Q16539_DB02195 | DB02195 | 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine | n/a | ZSMYZLKEZDYVPI-UHFFFAOYSA-N | ON1C2=CC=CN=C2C(=C1C1=CC=NC=C1)C1=CC=C(F)C=C1 | |
| 8 | Q16539_DB02277 | DB02277 | 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea | n/a | IC50(nM) = 794.0 Kd(nM) = 1160.0 kon(M-1-s-1) = 118000.0 koff(s-1) = 0.14 | FWIJKWMXNHRSRO-UHFFFAOYSA-N | CN1N=C(C=C1NC(=O)NC1=CC=C(Cl)C=C1)C(C)(C)C |
| 9 | Q16539_DB02352 | DB02352 | 3-(Benzyloxy)Pyridin-2-Amine | n/a | IC50(nM) = 100000.0 | NMCBWICNRJLKKM-UHFFFAOYSA-N | NC1=NC=CC=C1OCC1=CC=CC=C1 |
| 10 | Q16539_DB02873 | DB02873 | 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One | n/a | IC50(nM) = 2.6 | YAWZIQKDHQIHOS-UHFFFAOYSA-N | FC1=CC=C(C(F)=C1)C1=C2CNC(=O)N(C2=CC(=C1)N1CCNCC1)C1=C(Cl)C=CC=C1Cl |
| 11 | Q16539_DB02984 | DB02984 | 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline | n/a | FUSDVOSGGMBSMK-UHFFFAOYSA-N | COC1=CC2=NC=NC(NC3=CC(SC)=CC=C3)=C2C=C1OC | |
| 12 | Q16539_DB03044 | DB03044 | Doramapimod | n/a | Ki(nM) = 0.1 IC50(nM) = 0.1 Kd(nM) = 0.098 kon(M-1-s-1) = 84900.0 koff(s-1) = 8.0E-6 | MVCOAUNKQVWQHZ-UHFFFAOYSA-N | CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=C1C=CC=C2)C(C)(C)C |
| 13 | Q16539_DB03110 | DB03110 | 2-Chlorophenol | n/a | ISPYQTSUDJAMAB-UHFFFAOYSA-N | OC1=CC=CC=C1Cl | |
| 14 | Q16539_DB03980 | DB03980 | 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole | n/a | IC50(nM) = 25.0 | DFEYXQGDDCDXJK-UHFFFAOYSA-N | NC1=NC(=CC=N1)C1=C(N=CN1CC1CC1)C1=CC=C(F)C=C1 |
| 15 | Q16539_DB04338 | DB04338 | SB220025 | n/a | IC50(nM) = 19.0 | VSPFURGQAYMVAN-UHFFFAOYSA-N | NC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1 |
| 16 | Q16539_DB04632 | DB04632 | 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE | n/a | IC50(nM) = 6000.0 | JHHBGNIRSUTQAS-UHFFFAOYSA-N | OC1=C(CNC2CCN(CC2)S(=O)(=O)NC2=CC(OC3=CC=C(F)C=C3)=CC=C2)C=CC=C1 |
| 17 | Q16539_DB04797 | DB04797 | Triazolopyridine | n/a | IC50(nM) = 5.0 | OVCXRBARSPBVMC-UHFFFAOYSA-N | CC(C)C1=NN=C2C=CC(=CN12)C1=C(N=CO1)C1=CC=C(F)C=C1 |
| 18 | Q16539_DB05412 | DB05412 | Talmapimod | n/a | ZMELOYOKMZBMRB-DLBZAZTESA-N | [H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1 | |
| 19 | Q16539_DB05470 | DB05470 | VX-702 | n/a | FYSRKRZDBHOFAY-UHFFFAOYSA-N | NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F | |
| 20 | Q16539_DB06518 | DB06518 | R-1487 | n/a | KKKRKRMVJRHDMG-UHFFFAOYSA-N | CN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=C1N=C(NC1CCOCC1)N=C2 | |
| 21 | Q16539_DB06882 | DB06882 | 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea | n/a | IC50(nM) = 90.0 Kd(nM) = 12.0 | HJWMLCDGRWWLAQ-UHFFFAOYSA-N | CC(C)(C)C1=NN(C(NC(=O)NC2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(N)=C1 |
| 22 | Q16539_DB06940 | DB06940 | N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide | n/a | IC50(nM) = 3.1 EC50(nM) = 61.0 | ZZTMFGIGOADCFX-UHFFFAOYSA-N | CCNC(=O)C1=CN2N=CN=C(NC3=CC(=CC=C3C)C(=O)NOC)C2=C1C |
| 23 | Q16539_DB06991 | DB06991 | N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide | n/a | IC50(nM) = 3.5 | OYOUIHFZUAKCEF-LLVKDONJSA-N | [H][C@@](C)(CC)NC1=NC=C(S1)C(=O)NC1=C(C)C=CC(=C1)C(=O)NC |
| 24 | Q16539_DB07138 | DB07138 | Neflamapimod | n/a | Ki(nM) = 0.8 IC50(nM) = 9.0 Kd(nM) = 2.8 | VEPKQEUBKLEPRA-UHFFFAOYSA-N | FC1=CC(F)=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C=C1 |
| 25 | Q16539_DB07307 | DB07307 | N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide | n/a | Ki(nM) = 0.4 IC50(nM) = 0.8 | GQXMJOSCBRZMKE-UHFFFAOYSA-N | CC1=CC=CC=C1C1=NN=CC2=C1C=CC(=C2)C1=C(C)C=CC(=C1)C(=O)NC1CC1 |
| 26 | Q16539_DB07459 | DB07459 | 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE | n/a | IC50(nM) = 1500.0 | HVLSCZSVTCNAQX-UHFFFAOYSA-N | O=C(NCC1=NC=CC=C1)C1=CC=C(OC2=CC=CC=C2)C=C1 |
| 27 | Q16539_DB07607 | DB07607 | 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE | n/a | RXDZANYWRNIAOR-HHHXNRCGSA-N | C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC(I)=CC=C1)C1=CC=NC=C1 | |
| 28 | Q16539_DB07811 | DB07811 | N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide | n/a | Ki(nM) = 10.0 | UBVTVSINEVHYSY-UHFFFAOYSA-N | CC1=NN=C(O1)C1=CC=C(C(C)=C1)C1=CC(=CC=C1C)C(=O)NC1CC1 |
| 29 | Q16539_DB07829 | DB07829 | 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE | n/a | Ki(nM) = 600.0 IC50(nM) = 67.0 | BILJSHVAAVZERY-UHFFFAOYSA-N | FC1=CC=C(C=C1)C1=NNC=C1C1=CC=NC=C1 |
| 30 | Q16539_DB07832 | DB07832 | 4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde | n/a | Ki(nM) = 400.0 IC50(nM) = 2500.0 | VKQPTVJDZIILPG-UHFFFAOYSA-N | CC1=C(NC2=CC=NC3=CC(=CC=C23)C2=CSC(C=O)=N2)C=C(O)C=C1 |
| 31 | Q16539_DB07833 | DB07833 | N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide | n/a | Ki(nM) = 240.0 IC50(nM) = 1500.0 | PMMLSQFPBFKLHH-UHFFFAOYSA-N | CC1=NN=C(O1)C1=CC=C(C)C(=C1)C1=CC=C(C=C1)C(=O)NC1=CC(=CC=C1)C#N |
| 32 | Q16539_DB07834 | DB07834 | N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide | n/a | Ki(nM) = 480.0 IC50(nM) = 3000.0 | FOHZGCHKLPIBBX-UHFFFAOYSA-N | CC1=NN=C(O1)C1=CC=C(C)C(=C1)C1=CC=C(C=C1)C(=O)NCC1CC1 |
| 33 | Q16539_DB07835 | DB07835 | N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide | n/a | Ki(nM) = 9.0 IC50(nM) = 18.0 | BOPSUAHGQHFKGG-UHFFFAOYSA-N | CC1=CC=C(C=C1C1=CC=C(C=C1)C(=O)NCC1CC1)C(=O)NC1CC1 |
| 34 | Q16539_DB07941 | DB07941 | PH-797804 | n/a | Ki(nM) = 2.9 IC50(nM) = 1.1 Kd(nM) = 2.5 | KCAJXIDMCNPGHZ-UHFFFAOYSA-N | CNC(=O)C1=CC=C(C)C(=C1)N1C(C)=CC(OCC2=C(F)C=C(F)C=C2)=C(Br)C1=O |
| 35 | Q16539_DB07942 | DB07942 | 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine | n/a | YJCHZVXSPFPKMX-UHFFFAOYSA-N | FC1=CC=C(C=C1)C1=CNN=C1C1=CC(F)=NC=C1 | |
| 36 | Q16539_DB07943 | DB07943 | SD-0006 | n/a | CATQHDWESBRRQA-UHFFFAOYSA-N | OCC(=O)N1CCC(CC1)C1=NNC(=C1C1=CC=NC=N1)C1=CC=C(Cl)C=C1 | |
| 37 | Q16539_DB08064 | DB08064 | N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA | n/a | IC50(nM) = 350.0 | NTMADESEDXKNFZ-UHFFFAOYSA-N | CC(C)(C)C1=NNC(NC(=O)NC2=CC=C(Cl)C(COC3=CC=CN=C3)=C2)=C1 |
| 38 | Q16539_DB08068 | DB08068 | N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO- | n/a | YQJVDUKATDECHF-ICSRJNTNSA-N | [H][C@@]1(F)C[C@]([H])(CC(=C1)C(=O)NC1=CC=C(Cl)C(COC2=CN=CC=C2)=C1)N1CCOCC1 | |
| 39 | Q16539_DB08091 | DB08091 | 3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE | n/a | IC50(nM) = 630.0 | HIUFYIOMUILESI-UHFFFAOYSA-N | FC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=C(CCC3=CC=NC=C3)C2=C1)N1CCOCC1 |
| 40 | Q16539_DB08092 | DB08092 | 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide | n/a | IC50(nM) = 162000.0 | VMLSXFMXUNVCSK-UHFFFAOYSA-N | FC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=CC2=C1)N1CCOCC1 |
| 41 | Q16539_DB08093 | DB08093 | 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE | n/a | IC50(nM) = 44000.0 | SZANYTFSQVBOBA-UHFFFAOYSA-N | NC1=C(OCC2=CC=CC3=CC=CC=C23)C=CC=N1 |
| 42 | Q16539_DB08095 | DB08095 | 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA | n/a | IC50(nM) = 92.0 | ZWYFTKPEHRQCCW-HNNXBMFYSA-N | [H][C@@](C)(NC1=NC=CC(=N1)N(C(=O)NC1=CC=CC=C1Cl)C1=CC=C(OC)C=C1)C(C)(C)O |
| 43 | Q16539_DB08096 | DB08096 | 8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM | n/a | ZWKOUFZHPNIQSH-UHFFFAOYSA-N | CCN1C(NC2=CC=CC=C2Cl)=NC2=C1N=C(NC1=C(F)C=CC=C1F)N=C2 | |
| 44 | Q16539_DB08097 | DB08097 | 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE | n/a | OGWSGDLIXOEZJG-UHFFFAOYSA-N | CC(C)N1C(NC2=CC=CC=C2F)=NC2=CN=C(OC3=C(F)C=CC=C3F)N=C12 | |
| 45 | Q16539_DB08242 | DB08242 | N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | n/a | IC50(nM) = 10.0 | OYTBZXSFNNAVKU-UHFFFAOYSA-N | CNC(=O)C1=CC(NC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)=C(C)C=C1 |
| 46 | Q16539_DB08349 | DB08349 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | n/a | IC50(nM) = 3.2 | WMEYCLAVMZKZCS-UHFFFAOYSA-N | CN1C2=C(C=NN2C2=C(F)C=C(F)C=C2)C(NC2=C(C)C=CC(=C2)C(=O)NC2CC2)=CC1=O |
| 47 | Q16539_DB08351 | DB08351 | N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide | n/a | IC50(nM) = 0.9 | MNEXDVSJIUQQRH-UHFFFAOYSA-N | CC1=CC=C(C=C1C1=CC2=C(C=C1)N=C(NCCN1CCOCC1)N=C2)C(=O)NC1CC1 |
| 48 | Q16539_DB08352 | DB08352 | 6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine | n/a | IC50(nM) = 6.4 | FQYJTHIYAQQJAB-UHFFFAOYSA-N | CC(C)NC1=NC2=C(S1)C=C(C=C2)C1=C(N=CO1)C1=CC=CC=C1F |
| 49 | Q16539_DB08395 | DB08395 | 2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE | n/a | IC50(nM) = 460.0 | ZSOXFJURLPCSOO-UHFFFAOYSA-N | CCOCN1OC(=O)C(=C1C1=CC=NC(OC2=CC=CC=C2O)=N1)C1=CC=C(F)C=C1 |
| 50 | Q16539_DB08423 | DB08423 | [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE | n/a | QKZZJXRGCHXIAI-UHFFFAOYSA-N | NC1=C(C=NN1C1=CC=C(F)C=C1)C(=O)C1=CC(OC2CCNCC2)=CC=C1 | |
| 51 | Q16539_DB08424 | DB08424 | [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE | n/a | IC50(nM) = 180.0 | IJDQETGUEUJVTB-HNNXBMFYSA-N | [H][C@](O)(CO)COC1=CC(=CC=C1)C(=O)C1=C(N)N(N=C1)C1=CC=C(F)C=C1 |
| 52 | Q16539_DB08521 | DB08521 | 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine | n/a | CDMGBJANTYXAIV-HHHXNRCGSA-N | C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1 | |
| 53 | Q16539_DB08522 | DB08522 | 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE | n/a | IC50(nM) = 160.0 | ROKOFZNQCIIJMI-UHFFFAOYSA-N | FC1=CC=C(C=C1)C1=C(N(CC2CC2)C=N1)C1=CC=NC=C1 |
| 54 | Q16539_DB08730 | DB08730 | 3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE | n/a | IC50(nM) = 340.0 | CPFBZMFUCGHBAP-UHFFFAOYSA-N | FC1=CC(=CC(=C1)C(=O)NC1=CC=C2C=CN(CCC3=CC=NC=C3)C2=C1)N1CCOCC1 |
| 55 | Q16539_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |